In summary, the above results indicated that YANK2 promotes glioma growth by directly phosphorylating p70S6K and that there is a novel signaling pathway that is different from mTOR in activating p70S6K in glioma cells (Fig. 6I). Here, MTOR is linked to central nervous system cancer.